Who
Joel F. Sussman
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Galera Therapeutics.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $204K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Jan 2020
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 1 May 2025filed 5 May 2025 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 26 Jan 2021filed 28 Jan 2021 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 13 Nov 2020filed 16 Nov 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,606 at $0.00 | filing |
| 13 Nov 2020filed 16 Nov 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,755 at $0.00 | filing |
| 13 Nov 2020filed 16 Nov 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,639 at $0.00 | filing |
| 13 Nov 2020filed 16 Nov 2020 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code M | $3,8583,606 at $1.07 | filing |
| 13 Nov 2020filed 16 Nov 2020 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code M | $4,2813,755 at $1.14 | filing |
| 13 Nov 2020filed 16 Nov 2020 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code M | $6,4132,639 at $2.43 | filing |
| 13 Nov 2020filed 16 Nov 2020 | Galera TherapeuticsBiotechnology | SEC FORM 4 Sold | $103K10,000 at $10.32 | filing |
| 12 Nov 2020filed 16 Nov 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 12 Nov 2020filed 16 Nov 2020 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code M | $11K10,000 at $1.07 | filing |
| 12 Nov 2020filed 16 Nov 2020 | Galera TherapeuticsBiotechnology | SEC FORM 4 Sold | $101K10,000 at $10.06 | filing |
| 31 Jan 2020filed 4 Feb 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,263 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.